Features of haemophilus influenzae type b vaccine in patients waitlisted for lung transplantation

Objective: to evaluate the immunological efficacy of haemophilus influenzae type b (Hib) vaccine in patients with severe bronchopulmonary condition waitlisted for lung transplantation.

Materials and methods. 16 patients (age 22–61 years) with severe bronchopulmonary diseases were vaccinated once against Hib infection. IgG antibody concentrations to Hib capsular polysaccharide before vaccination and 1 month after was measured by ELISA using a test system developed at Mechnikov Research Institute of Vaccines and Sera. Statistical data processing was carried out using stats (v.3.6.2), lme4 (v.1.1 – 21), and lmerTest (v.3.1 – 1) packages.

Results. Hib vaccine in patients with severe bronchopulmonary condition did not elicit any local or systemic reactions. The proportion of patients whose antibody (Ab) concentrations to Hib capsular polysaccharide exceeded the long-term protection threshold was 69% and 100% before and after vaccination, respectively (p = 0.02). There were differences in the formation of post-vaccination immunity depending on the nosological forms of patients’ diseases. In the group of patients with obstructive pulmonary diseases, the geometric mean level of antibodies to the Hib capsular polysaccharide after vaccination increased as compared to the baseline  value – from 1.3 [0.6–2.8] to 5.5 [1.9–15.4] AU/mL, (p = 0.05). In the group of patients with restrictive lung diseases, the level did not change – 2.8 [0.6–14.1] AU/mL before vaccination and 3.4 [1.3–8.5] AU/mL 1 month after vaccination. In the group of patients taking glucocorticosteroids, there was no increase in the level of antibodies to Hib capsular polysaccharide (2.7 [0.8–9.3] AU/mL before and 2.8 [1.2–6.5] AU/mL after vaccination). In the group of patients who did not take hormones, antibody concentrations to Hib capsular polysaccharide increased from 1.2 [0.7–2.1] AU/mL to 4.8 [2.2–10.1] AU/mL (p = 0.006).

Conclusion. Hib vaccination of waitlisted patients with severe bronchopulmonary disease is safe and immunologically effective. 

1. Epidemiologiya i vaktsinoprofilaktika infektsii, vyzyvaemoy Haemophilus influenzae tipa b: Metodicheskie rekomendatsii. M.: Federal’nyy tsentr gigieny i epidemiologii Rospotrebnadzora, 2010. 32. [In Russ].

2. Namazova LS, Kostinov MP, Volkova ON, Tatochenko VK, Galitskaya MG, Izvol’skaya ZA et al. Profilaktika grippa, ORI, pnevmokokkovoy, meningokokkovoy i Hib-infektsii y chasto boleyushchikh detey (posobie dlya vrachey). M.: Federal’noe agentstvo po zdravookhraneniyu i sotsial’nomu razvitiyu, 2006. 43. [In Russ].

3. Kostinov MP, Lavrov VF. Vaktsiny novogo pokoleniya v profilaktike infektsionnykh zabolevaniy (izdanie 2-e, dopolnennoe). M.: MDV, 2010. 192. [In Russ].

4. Haemophilus influenzae type b (Hib) Vaccination Position Paper. Weekly epidemiological record. 2013; 88, 39: 413–428. http://www.who.int/wer.

5. WHO Immunization coverage. https://www.who.int/en/news-room/fact-sheets/detail/ immunization-coverage

6. Cassimos DC, Effraimidou E, Medic S, Konstantinidis T, Theodorido M, Maltezou HC. Vaccination Programs for Adults in Europe, 2019. Vaccines (Basel). 2020; 8 (1): 34. doi: 10.3390/vaccines8010034. doi: 10.3390/vaccines8010034.

7. Professional methodical introduction for implementation mandatory and recommended immunization of active population [In Serbian]. http://www.batut.org.rs/download/publikacije/SMU%20imuinizacija.pdf 6.

8. Yastrebova NE, Vaneeva NP, Markina OA, Orlova OE, Elkina SI, Kostinov MP et al. Sposob opredeleniya antitel k kapsul’nomu polisakharidu Haemophilus influenzae tipa b. Patent na izobretenie RUS № 2331075. Zayavka № 2006133787/15 ot 22.09.2006. Opubl. 10.08.2008. [In Russ].

9. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols. Clin Microbiol Rev. 2003; 16 (3): 357–364. doi: 10.1128/CMR.16.3.357-364.2003.

10. Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis. 2001; 33 Suppl 1: 58–65. doi: 10.1086/320906.

11. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc. 2009; 6 (1): 94–100. doi: 10.1513/pats.200809-113GO.

12. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med. 1999; 340 (14): 1081–1091. doi: 10.1056/NEJM199904083401406.

13. Kostinov MP, Kostinov AM, Pakhomov DV, Polishchuk VB, Kostinova AM, Shmitko AD et al. Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients. Journal of Microbiology Epidemiology Immunobiology. 2019; 5: 72–83. [In Russ, English abstract]. doi: 10.36233/0372-9311-2019-5-72-83.

14. Chuchalin AG, ed. Respiratornaya meditsina. Rukovodstvo v 3 tomakh. 2-e izdaniye, pererabotannoye i dopolnennoye. T. 2. M.: Litterra, 2017. 544. [In Russ].

15. Kostinov MP, Zverev VV, eds. Vaktsinatsiya protiv gepatita B, grippa i krasnukhi vzroslykh patsientov s khronicheskimi zabolevaniyami. Prakticheskoe rukovodstvo. M.: MDV, 2009. 196. [In Russ].

16. Kostinov MP, Chuchalin AG, eds. Rukovodstvo po klinicheskoj immunologii v respiratornoj medicine. 1st ed. M.: ATMO, 2016. 128. [In Russ].

17. Briko NI, Simonova EG, Kostinov MP, Zhirova SN, Kozlov RS, Murav’yev AA. Immunoprofilaktika pnevmokokkovykh infektsiy. Uchebno-metodicheskoye posobiye. N.N.: Remedium Privolzh’ye, 2013. 278. [In Russ].

18. Chuchalin AG, Bilichenko TN, Osipova GL, Kurbatova EA, Egorova NB, Kostinov MP. Vaccine prevention of respiratory diseases in the framework of primary health care to the population. Russian Pulmonology. Supplement. 2015; 2 (25): 1–19. [In Russ.].

19. Ryzhov AA, Kostinov MP, Magarshak OO. Primeneniye vaktsin protiv pnevmokokkovoy i gemofil’noy tipa b infektsiy u lits s khronicheskoy patologiyey. Epidemiologiya i vaktsinoprofilaktika. 2004; 6 (19): 24–27. [In Russ].

20. Markelova EV, Gushchina YaS, Kostinov MP, Zhuravleva NV. Clinical and immunological effect produced by vaccination with «Pneumo 23» of children with atopic bronchial asthma. Journal of Microbiology Epidemiology Immunobiology. 2005; 2: 83–85. [In Russ, English abstract].

21. Protasov AD, Zhestkov AV, Lavrenteva NE, Kostinov MP, Ryzhkov AA. Effect of complex vaccination against pneumococcal, haemophilus type b infections and influenza in patients with chronic obstructive pulmonary disease. Journal of Microbiology Epidemiology immunobiology. 2011; 4: 80–84. [In Russ, English abstract].

22. Kostinov MP, ed. Novoye v klinike, diagnostike i vaktsinoprofilaktike upravlyayemykh infektsiy. M.: Meditsina, 1997. 110.

23. Garashchenko TI, Kostinov MP, Ilienko LI, Kyt’ko OV, Garashchenko MV, Foshina YeP et al. Preventive and therapeutic application of Hib and pneumococcal vaccines among children, who are prone to frequent and prolonged recurrent otitis media. Current Pediatrics. 2006; 5 (5): 24–28. [In Russ, English abstract].

24. Ilienko LI, Kostinov MP, Garashchenko MV, Kyt’ko OV, Ovechkina NV, Kats TP. Vaccine immunization for prevention of pneumococcal, haemophilus influenzae and flu among sickly children, who often suffer from persistent heterospecific infectious pathology of the bronchopulmonary system. Current Pediatrics 2006; 5 (4): 27–30. [In Russ, English abstract].

25. Kostinov MP, Maleev VV. Hib-infektsiya: voprosy vaktsinoprofilaktiki. M.: Meditsina dlya vsekh, 1998. 90. [In Russ].

26. Livorsi DJ, MacNeil JR, Cohn AC, Bareta J, Zansky S, Petit S et al. Invasive Haemophilus influenzae in the United States, 1999–2008: Epidemiology and Outcomes. J Infect. 2012; 65 (6): 496–504. doi: 10.1016/j.jinf.2012.08.005.

27. Soeters HM, Blain A, Pondo T, Doman B, Farley MM, Harrison LH et al. Current Epidemiology and Trends in Invasive Haemophilus Influenzae Disease-United States, 2009–2015. Clin Infect Dis. 2018; 67 (6): 881–889. doi: 10.1093/cid/ciy187.

28. Infektsionnoe obostrenie KhOBL: Prakticheskie rekomendatsii po diagnostike, lecheniyu i profilaktike. Posobie dlya vrachey. M., 2005. 37.

29. Kostinov MP, ed. Vaktsinatsiya vzroslykh s bronkholegochnoy patologiey. Rukovodstvo dlya vrachey. M.: Sozvezdie, 2013. 112.

30. Ladhani SN, Ramsay ME, Flood JS, Campbell H, Slack MP, Pebody R et al. Haemophilus influenzae serotype b (Hib) seroprevalence in England and Wales in 2009. Euro Surveill. 2012; 17 (46): 20313. doi: 10.2807/ese.17.46.20313-en.

31. Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S et al. Risk of Invasive Haemophilus influenza type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era. Clin Vaccine Immunol. 2012; 19 (5): 766–771. doi: 10.1128/CVI.05675-11.

32. Kostinov MP, Protasov AD, Zhestkov AV, Pakhomov DV, Chebykina AV, Kostinova TA. Post-vaccination Immunity to Pneumococcal, Haemophilus Influenzae type b Infection and Influenza in Patients with Chronic Obstructive Pulmonary Disease (COPD). J Vaccines Vaccin. 2014; 5: 2. doi: 10.4172/2157-7560.1000221.

33. Kostinov MP, red. Primenenie vaktsin «PNEVMO 23» i «Akt-KhIB» v komplekse lechebno-profilakticheskikh meropriyatiy pri khronicheskikh vospalitel’nykh zabolevaniyakh legkikh u detey: posobie dlya vrachey. M.: Meditsina dlya vsekh, 2004. 46.

34. Kostinov MP, ed. Rasshirenie kompleksa lechebno-profilakticheskikh meropriyatiy pri bronkhial’noy astme u detey s primeneniem vaktsin «PNEVMO-23» i «Act-KhIB». Posobie dlya vrachey. M.: Meditsina dlya vsekh, 2004. 36. [In Russ].

35. Korovkina ES, Krakovskaya AV, Kostinov MP, Kozlov VK, Jastrebova NE, Magarshak OO et al. Dynamics in IgM and IgG antibodies against a polysaccharide capsule-containing complex of various S. pneumoniae and H. influenzae type b serotypes in children with chronic lung and bronchial inflammatory diseases after vaccination with «Pneumo-23» and «Act-HIB». Russian Journal of Infection and Immunity (2019), 9 (5–6): 713–722. [In Russ, English abstract]. doi: 10.15789/2220-7619-2019-5-6-713-722.